New research compared the effect of semaglutide vs. tirzepatide on weight loss over a 72 week period. Here's what the study ...

Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions ...

In a head-to-head tussle between two obesity drugs, tirzepatide came out on top of semaglutide for weight loss, according to top-line results from the SURMOUNT ... On average, tirzepatide cut body ...

Long-term tirzepatide ... return close to baseline. Uncertainty remains regarding what happened with appetitive behavior,” Le Roux said. “We can now shift the focus away from weight loss ...

With respect to weight loss, more participants treated with tirzepatide had reductions in body weight of at least 10%, 15%, 20%, and 25%. More than 80% of those who received tirzepatide lost 10% of ...

The FDA has approved tirzepatide for diabetes and weight management. To get an online tirzepatide prescription, you’ll need to undergo a remote consultation with a state-licensed physician ...

Tirzepatide is the active ingredient in Zepbound, approved by the Food and Drug Administration (FDA) specifically for weight loss. Semaglutide was initially approved under the brand name Ozempic ...

Tirzepatide (trade name Zepbound) promoted greater weight loss in individuals with obesity than did semaglutide ... who lost an average of 33 pounds or 13.7% of their baseline weight. The results of ...

Participants given tirzepatide lowered their HbA1c by a mean 0.77% more than those given a higher dulaglutide dose. More tirzepatide participants hit a weight loss threshold known for disease ...

Compared with semaglutide and insulin, tirzepatide was associated with improved glycemic control and weight loss outcomes among ... reduction in body weight from baseline on the basis of receiving ...

A major 72-week trial shows tirzepatide leads to double-digit weight loss and greater waist reduction ... Randomization was stratified by sex, baseline BMI, and prediabetes status.

May 12, 2025 – Turns out, two really is better than one – at least when it comes to weight loss drugs. In the first head-to-head trial of its kind, people with obesity who took tirzepatide ...